Follow us:

Tel: +44 (0) 1904 406082

Abingdon Health develops, manufactures and markets innovative medical diagnostics for clinics and laboratories worldwide to enable rapid, accurate, and low-cost diagnosis.

Our initial development focus is in the field of haematology oncology and specifically in the area of B-Cell dyscrasias. Our first rapid testing product in this market is Seralite® – FLC, the world’s first rapid device for aiding the diagnosis and monitoring of multiple myeloma patients.

Seralite® – FLC Serum

Rapid test for the quantitative measurement of free light chains (FLCs) in diagnosis and monitoring of multiple myeloma.

Read More

Seralite® – FLC Urine

  A rapid test for the quantitative measurement of kappa (K) and […]

Read More

Seralite® – FLC ELISA

Accurate measurement of both kappa and lambda free light chains (FLCs) across a diverse range of patient cohorts.

Read More

Clinical Utility

Clinicians are able to better understand disease status and can make informed decisions quickly and efficiently.

Read More

Technical Support

Contact us for sales assistance, technical support and further product information.

Read More